Recent News

522 News Items found
Pictured: Ken Marians, Lorenz Studer, Greg Safko, Susan Bancroft & Yvonne Gruber
Gerstner Sloan Kettering Student Awarded Melanoma Research Grant
Fourth-year student Yvonne Gruber was awarded a $10,000 melanoma research grant by the Joanna M. Nicolay Melanoma Foundation.
Viviane S. Tabar
Memorial Sloan Kettering Researchers Show Brain Tumors Make Their Own Blood Vessels from Stem Cells
Memorial Sloan Kettering Cancer Center researchers have published new findings that may help explain why brain tumors called glioblastomas are so resistant to treatment.
Pictured: Justin Miller
Second Year Student Wins National Science Foundation Graduate Research Fellowship
Second-year student Justine Miller has received a 2011 National Science Foundation Graduate Research Fellowship Program Fellowship.
Pictured: Craig Thompson
Student Lecture Highlights Major Trends in Modern Cancer Research
More than 500 high school students and their teachers filled the Rockefeller Research Laboratories to learn about recent discoveries.
Study Elucidates How Antibiotics Can Increase Some Harmful Infections in Cancer Patients
An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract.
Sloan Kettering Institute Director Thomas J. Kelly
Thomas Kelly Honored
Sloan Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University.
Participants in Cycle for Survival
Treating Rare Cancers
Memorial Sloan Kettering physicians have experience and specialized expertise in caring for people with uncommon cancers.
Jedd Wolchok
Novel Immunotherapy Drug Receives FDA Approval for the Treatment of Metastatic Melanoma
The US Food and Drug Administration announced today that the drug ipilimumab (brand name Yervoy) has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.
Pictured: Dimiter Tassev
First Gerstner Sloan Kettering Student Receives PhD Degree
Dimiter Tassev, a member of Gerstner Sloan Kettering's inaugural class, has completed all his degree requirements and will receive his PhD in May.
Memorial Sloan Kettering President Craig Thompson Welcomes Prospective Gerstner Sloan Kettering Students
Memorial Sloan Kettering Cancer Center and Gerstner Sloan Kettering President Craig Thompson and his wife opened their home for a reception for prospective Gerstner Sloan Kettering students invited for admissions interviews.